Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

PhaseBio Pharmaceuticals Q1 EPS $(0.23) Up From $(0.87) YoY

PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.23) per share. This is a 73.56 percent increase over losses of $(0.87) per share from the same period last year.

byBenzinga Newsdesk

May 16, 2022

1 minute read

PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.23) per share. This is a 73.56 percent increase over losses of $(0.87) per share from the same period last year.

A Look Into Keurig Dr Pepper’s Debt

By Benzinga Insights

Today, 2:38 PM

Shares of Keurig Dr Pepper Inc. (NASDAQ:KDP) fell by 8.64% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.

KDP

Agree Realty Priced 5M Share Offering @$68.65/Share

By Charles Gross

Today, 2:38 PM

Agree Realty Corporation (NYSE: ADC) (the "Company") today announced the pricing of its public offering of 5,000,000 shares of its common stock at a public offering price of $68.65 per share in connection with the forward sale agreements described below.

ADC